A survey conducted in April and May 2023 revealed that around ** percent of the companies that do business in the European Union (EU) and the United Kingdom (UK) found it challenging to adapt to new or changing requirements of the General Data Protection Regulation (GDPR) or Data Protection Act 2018 (DPA). A further ** percent of the survey respondents said it was challenging to increase the budget because of the changes in the data privacy laws.

A survey conducted in April and May 2023 revealed that around 35 percent of organizations in the United States and 40 percent of organizations in the United Kingdom pay higher costs for international data transfers due to data privacy regulations, but they also find it manageable. Furthermore, approximately 35 percent of respondents from both countries think the regulations encourage businesses by guaranteeing that the data will be safeguarded in other countries.

A survey conducted in April and May 2023 found that less than half of the surveyed organizations in the United States and the United Kingdom (UK) had completed selected actions to comply with state data privacy laws in the United States. Around ** percent of the respondents had made a comparison of the United States' state-level privacy law frameworks. A further ** percent said they were in the process of doing so. Furthermore, ** percent of the respondents said they had updated privacy policies, while almost ** percent were in the process of planning and conducting data assessments.

This is because it would breach the first data protection principle as: a) it is not fair to disclose claimant personal details to the world and is likely to cause damage or distress. b) these details are not of sufficient interest to the public to warrant an intrusion into the privacy of the claimant. Please click the below web link to see the exemption in full. https://www.legislation.gov.uk/ukpga/2000/36/section/40 Breach of Patient confidentiality Please note that the identification of claimants is also a breach of the common law duty of confidence. A claimant who has been identified could make a claim against the NHSBSA or yourself for the disclosure of the confidential information. The information requested is therefore being withheld as it falls under the exemption in section 41(1) ‘Information provided in confidence’ of the Freedom of Information Act. Please click the below web link to see the exemption in full.

This dataset is about books. It has 4 rows and is filtered where the book is Data protection : a practical guide to UK and EU law. It features 7 columns including author, publication date, language, and book publisher.

A survey conducted in April and May 2023 revealed that around a quarter of United States and United Kingdom organizations were highly concerned about data privacy law enforcement involving their company. A further 35 percent were worried about data breaches and other cybersecurity incidents. Dealing with high costs of privacy law compliance was a concern for approximately 20 percent of the respondents.

As of February 2025, the largest fine issued for violation of the General Data Protection Regulation (GDPR) in the United Kingdom (UK) was more than 22 million euros, received by British Airways in October 2020. Another fine received by Marriott International Inc. in the same month was the second-highest in the UK and amounted to over 20 million euros.

This report is one outcome of a study into privacy and human genetics initiated by John Gillott and staff and trustees of the Genetic Interest Group. \ud \ud The initial focus was on genetics and human rights, with an emphasis on legal aspects and policy decisions informed by law and rights ideology. Article 8 of the Human Rights Act 1998, the right to respect for private and family life,1 is of most relevance to this study, though other Articles are considered.\ud \ud The study as a whole comprises two broad strands of inquiry, reflecting those areas in which privacy rights are most relevant and have had the greatest impact: the effect of law and ideology on research and clinical practice, with a focus on genetics; and human reproduction, again with a particular focus on genetic aspects. These two areas present contrasting analytical challenges. While there is recent law indirectly or directly relevant to research and clinical practice (notably the Human Tissue Act 2004), there is little or no case law on the subject. In contrast, as regards reproduction and genetics, there have, over the past five years or so, been a number of court decisions, at all levels up to the House of Lords and the European Court of Human Rights. We therefore decided to publish the results of our study into the two areas separately, the better to highlight the key issues in each subject area. This report is on the first strand: the right to privacy in the context of medical research using tissue and data.

a - it is not fair to disclose individual’s personal details to the world and is likely to cause damage or distress. b - these details are not of sufficient interest to the public to warrant an intrusion into the privacy of the individual. Please click the below web link to see the exemption in full. www.legislation.gov.uk/ukpga/2000/36/section/40 Breach of confidentiality Please note that the identification of individuals is also a breach of the common law duty of confidence. An individual who has been identified could make a claim against the NHSBSA for the disclosure of the confidential information. The information requested is therefore being withheld as it falls under the exemption in section 41(1) ‘Information provided in confidence’ of the Freedom of Information Act. Please click the below web link to see the exemption in full.

A survey of UK young adults between 18 and 34 years in October 2023 found that ethnic minorities tend to exercise their data protection rights. Around 33 percent of respondents representing ethnic minorities said they had refused to provide their biometric data, compared to 22 percent of white respondents. Similarly, young people of color were more likely to ask an organization to stop using their personal information.

Response to DCMS 'Data: A New Direction' consultation on reforms to UK data protection law following the UK’s departure from the European Union by British and Irish Law Education Technology Association.; Mc Cullagh, Chapter 3, pp.31-35

Dataset on commits (and repositories) on GitHub making reference to data privacy legislation (covering laws: GDPR, CCPA, CPRA, UK DPA).

The dataset contains:
+ all_commits_info_merged-v2-SHA.csv : commits information as collected from various GitHub REST API calls (all data merged together).
+ repos_info_merged_USED-v2_with_loc.csv: repository information with some calculated data.
+ top-70-repos-commits-for-manual-check_commits-2coders.xlsx: results of the manual coding of the commits of the 70 most popular repositories in dataset.
+ user-rights-ω3.csv: different terms for user rights teriminology in legislation.
+ github_commits_analysis_replication.r: main analysis pipeline covering all RQs in the R programming language.

In order to perform also the initial data collection, the GitHub REST API can be used, collecting data using time intervals, for instance:
https://api.github.com/search/commits?q=%22GDPR%22+committer-date:2018-05-25..2018-05-30&sort=committer-date&order=asc&per_page=100&page=1

This dataset accompanies the following publication, so please cite it accordingly:

Georgia M. Kapitsaki, Maria Papoutsoglou, Evolution of repositories and privacy laws: commit activities in the GDPR and CCPA era, accepted for publication at Elsevier Journal of Systems & Software, 2025.

A study, conducted in April 2024 among digital services companies in the United Kingdom (UK) showed that 63 percent of them had age assurance methods in place. Furthermore, 26 percent said they had none, and 11 percent were not aware of such measures.

Please be aware that I have decided not to release the full details where the total number of individuals falls below five. This is because the information is exempt under section 40(2) of the FOIA (personal information). This is because it would breach the first data protection principle as: a. it is not fair to disclose individual’s personal details to the world and is likely to cause damage or distress b. these details are not of sufficient interest to the public to warrant an intrusion into the privacy of the individual Please see the following link to view the section 40 exemption in full: https://www.legislation.gov.uk/ukpga/2000/36/section/40 Breach of Confidentiality Please note that the identification of individuals is also a breach of the common law duty of confidence. An individual who has been identified could make a claim against the NHSBSA for the disclosure of the confidential information. The information requested is therefore being withheld as it falls under the exemption in section 41(1) ‘Information provided in confidence’ of the Freedom of Information Act. Please see the following link to view the section 41 exemption in full: https://www.legislation.gov.uk/ukpga/2000/36/section/41

This is because it would breach the first data protection principle as: a) it is not fair to disclose patients’ personal details to the world and is likely to cause damage or distress. b) these details are not of sufficient interest to the public to warrant an intrusion into the privacy of the patients. Please click the below web link to see the exemption in full. https://www.legislation.gov.uk/ukpga/2000/36/section/40 Breach of Patient confidentiality Please note that the identification of patients is also a breach of the common law duty of confidence. A patient who has been identified could make a claim against the NHSBSA or yourself for the disclosure of the confidential information. The information requested is therefore being withheld as it falls under the exemption in section 41(1) ‘Information provided in confidence’ of the Freedom of Information Act. Please click the below web link to see the exemption in full. https://www.legislation.gov.uk/ukpga/2000/36/section/41 Questions 2 & 3 The COVID-19 vaccines are very new and the global effort to establish any potential causal relationship between the vaccines and their potential adverse effects is not straightforward and has taken time. Claims relating to Covid-19 vaccines have not yet been medically assessed, therefore there have been no payments made to date. Question 4 There have been fewer than 5 claims rejected due to those claims falling outside the eligibility criteria. Therefore this information is being withheld under the same exemption outlined in the response to question 1 above. Data Queries

A study, conducted in April 2024 among digital services companies in the United Kingdom (UK) with products and services aimed at those 18 years and older, found that nearly half of them were not aware of underage users attempting to use their products and services. Furthermore, 40 percent said they were aware of it, while 12 percent were not sure.

Snapshot img

Customer Data Platform Market Size 2024-2028

The customer data platform market size is forecast to increase by USD 19.02 billion at a CAGR of 32.12% between 2023 and 2028.

The customer data platform (CDP) market is experiencing significant growth due to several key trends. The increasing demand for personalized customer services in various industries, particularly e-commerce retail, is driving market growth. This trend is being fueled by the rising preference for omnichannel platforms that enable seamless customer interactions across multiple touchpoints. Additionally, the need to address customer data privacy concerns is another major factor contributing to the market's growth.
As businesses strive to provide more personalized experiences to their customers while ensuring data security, CDPs and workforce analytics are becoming an essential tool for managing and activating customer data in real time. This CDP market analysis report provides a comprehensive examination of these trends and other growth factors, offering valuable insights for businesses looking to leverage CDPs to enhance their customer engagement strategies.

What will be the Size of the Customer Data Platform Market During the Forecast Period?

Request Free Sample

The customer data platform (CDP) market is experiencing significant growth due to the increasing importance of customer intelligence for delivering omnichannel experiences. Businesses seek to understand their customers across multiple channels and touchpoints, requiring the ability to handle large volumes of complex data. CDP solutions enable data unification and identity resolution, ensuring accurate and consistent customer profiles. Data governance and privacy laws are driving the need for robust data protection and security measures, including data breach prevention and compliance with regulations such as GDPR and CCPA.
Additionally, AI and machine learning are being integrated into CDPs to enhance data analytics capabilities, providing valuable insights for industries like healthcare, telecom, travel and hospitality, and advertising.
The customer data platform market is evolving with AI-powered CDP solutions enhancing real-time data processing, customer data integration, and omnichannel marketing. Businesses focus on data privacy compliance and first-party data management to drive predictive analytics, customer segmentation, and personalized marketing. Cloud-based CDP adoption supports customer journey analytics, CDP for e-commerce, and cross-channel data activation. Data monetization strategies, identity resolution, and enterprise CDP solutions fuel CDP market growth, enabling data-driven customer insights and customer retention strategies.
Big data and real-time data processing are essential features, enabling businesses to make informed decisions and respond quickly to customer needs.

How is this Customer Data Platform Industry segmented and which is the largest segment?

The customer data platform industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

Deployment

  On-premises
  Cloud based


End-user

  Large enterprises
  Small and medium size enterprises


Geography

  North America

    US


  Europe

    Germany
    UK


  APAC

    China
    Japan


  South America



  Middle East and Africa

By Deployment Insights

The on-premises segment is estimated to witness significant growth during the forecast period.

The on-premises the market is experiencing substantial growth due to its ability to process and personalize customer data while maintaining data security within an organization's data centers or servers. On-premises CDPs offer customizable solutions tailored to specific business needs and unique data processing workflows, which may not be available in cloud-based alternatives. However, the need to upgrade hardware for data scalability is a consideration for on-premises CDPs. Key features of on-premises CDPs include data unification, identity resolution, data governance, data privacy, and data security. These platforms enable organizations to comply with data privacy laws, protect against data breaches, and address consumer concerns.

On-premises CDPs are particularly valuable for industries with large data volumes and complexities, such as advertising, healthcare services, telecom, media and entertainment, retail, and travel and hospitality. Integration with mobile devices, Short Message Service, and communication channels is essential for providing a seamless omnichannel experience. Machine learning and natural language processing technologies enhance data analysis and personalization capabilities. Cloud-based technology offers flexibility and cost savings, but on-premises CDP